Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.60 |
| ▸ | MAPT | P10636 | 4/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.60 |
| ▸ | GAA | P10253 | 2/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | IDE | P14735 | 1/20 | 0.57 |
| ▸ | MYC | P01106 | 1/20 | 0.49 |
| ▸ | PDE4A | P27815 | 1/20 | 0.49 |
| ▸ | BLVRB | P30043 | 1/20 | 0.49 |
| ▸ | KDR | P35968 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.48 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6807307 | 1.00 | MEN1 (0.60) | MEN1KMT2AMAPTNPSR1GAA | |
| SCHEMBL6812002 | 0.86 | MEN1 (0.62) | MEN1KMT2AMAPTNPSR1GAA | |
| SCHEMBL25270006 | 0.82 | MEN1 (0.74) | MEN1KMT2AMAPTNPSR1GAA | |
| SCHEMBL29377614 | 0.82 | MEN1 (0.74) | MEN1KMT2AMAPTNPSR1GAA | |
| SCHEMBL8180620 | 0.81 | MEN1 (0.51) | MEN1KMT2AMAPTNPSR1GAA | |
| SCHEMBL6806131 | 0.81 | MEN1 (0.56) | MEN1KMT2AMAPTNPSR1GAA | |
| SCHEMBL21067788 | 0.78 | KMT2A (0.69) | MEN1KMT2AMAPTNPSR1GAA | |
| SCHEMBL8180628 | 0.76 | MEN1 (0.53) | MEN1KMT2AMAPTNPSR1GAA | |
| SCHEMBL21067463 | 0.75 | MEN1 (0.64) | MEN1KMT2AMAPTNPSR1GAA | |
| SCHEMBL6807136 | 0.74 | MEN1 (0.51) | MEN1KMT2AMAPTNPSR1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6602987-B1 | 4'-hydroxyazobenzene-2-carboxylic acid (HABA) compounds; useful as reagents for labeling, isolation and detection of biological molecules | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 2003-08-05 | — | — | US | claimed |
| WO-2000027813-A1 | AZOBENZENE DERIVATIVES AS LABELING AGENTS AND INTERMEDIATES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2000-05-18 | — | — | WO | claimed |
| US-20040067229-A1 | Azobenzene derivatives as labeling agents and intermediates thereof | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2004-04-08 | — | — | US | disclosed |
| US-6602987-B1 | 4'-hydroxyazobenzene-2-carboxylic acid (HABA) compounds; useful as reagents for labeling, isolation and detection of biological molecules | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 2003-08-05 | — | — | US | disclosed |
| WO-2000027813-A1 | AZOBENZENE DERIVATIVES AS LABELING AGENTS AND INTERMEDIATES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2000-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040067229-A1 | Azobenzene derivatives as labeling agents and intermediates thereof | CBR1, CBR3, HBB | MEN1 2043/4885KMT2A 1572/4885MAPT 2644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.